Alpha 2.0
Login Register
» Articles » PMID: 16009909

Ethnic Differences in Acetylcholinesterase Inhibitor Use for Alzheimer Disease

Overview
Journal Neurology
Specialty Neurology
Date 2005 Jul 13
PMID 16009909
Citations 37
Authors
Kala M Mehta
Maggie Yin
Cynthia Resendez
Kristine Yaffe
Affiliations
Soon will be listed here.
Abstract

Acetylcholinesterase inhibitors (AChIs) have been demonstrated to improve Alzheimer disease symptoms. Whether the use of AChIs varies by ethnicity is unknown. More than 2500 ethnically diverse patients (6% African American, 14% Latino, and 7% Asian patients) from the Alzheimer's Disease Research Centers in California were studied. Compared with white patients with AD, minority patients had 40% lower odds of AChI use (odds ratio 0.6, 95% confidence interval: 0.5 to 0.7).

Citing Articles

Validation of dementia care-related scales among informal caregivers of Latinos with dementia or mild cognitive impairment.

Perales-Puchalt J, Checa I, Espejo B, de la C Martin Carbonell M, Fracachan-Cabrera M, Baker C medRxiv. 2024; .

PMID: 39252909 PMC: 11383477. DOI: 10.1101/2024.08.28.24312743.

Impact of the COVID-19 Pandemic on Latino Families With Alzheimer Disease and Related Dementias: Qualitative Interviews With Family Caregivers and Primary Care Providers.

Perales-Puchalt J, Peltzer J, Fracachan-Cabrera M, Perez G, Ramirez M, Greiner K JMIRx Med. 2024; 5:e42211.

PMID: 38488740 PMC: 11004515. DOI: 10.2196/42211.

Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.

Dong X, Tsang C, Wan J, Chisholm-Burns M, Finch C, Tsao J Explor Res Clin Soc Pharm. 2024; 13:100420.

PMID: 38420610 PMC: 10900920. DOI: 10.1016/j.rcsop.2024.100420.

Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review.

Hinton L, Tran D, Peak K, Meyer O, Quinones A Alzheimers Dement. 2024; 20(4):3000-3020.

PMID: 38265164 PMC: 11032576. DOI: 10.1002/alz.13612.

Immigration and access to dementia diagnostics and treatment: A nationwide study in Sweden.

Hoang M, Kareholt I, Lindgren E, von Koch L, Xu H, Tan E SSM Popul Health. 2024; 25:101573.

PMID: 38162224 PMC: 10755485. DOI: 10.1016/j.ssmph.2023.101573.

References
1.
Briesacher B, Limcangco R, Gaskin D . Racial and ethnic disparities in prescription coverage and medication use. Health Care Financ Rev. 2004; 25(2):63-76. PMC: 4194807. View
2.
Demirovic J, Prineas R, Loewenstein D, Bean J, Duara R, Sevush S . Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol. 2003; 13(6):472-8. DOI: 10.1016/s1047-2797(02)00437-4. View
3.
Valle R, Lee B . Research priorities in the evolving demographic landscape of Alzheimer disease and associated dementias. Alzheimer Dis Assoc Disord. 2002; 16 Suppl 2:S64-76. DOI: 10.1097/00002093-200200002-00006. View
4.
Sink K, Covinsky K, Newcomer R, Yaffe K . Ethnic differences in the prevalence and pattern of dementia-related behaviors. J Am Geriatr Soc. 2004; 52(8):1277-83. DOI: 10.1111/j.1532-5415.2004.52356.x. View
5.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View